Abstract
Rare mutations in several genes have a critical role in the control of homeostatic mechanisms such as food-intake, energy balance and glucose metabolism. In this study, we performed a mutational screening in a 58-year-old woman presenting early-onset type 2 diabetes and central obesity. The entire coding regions of MC4R, MC3R, HNF1A, GCK and POMC (pro-opiomelanocortin) genes were analyzed by direct sequencing. A new missense mutation was identified within the POMC gene signal peptide sequence, resulting in a heterozygous substitution of an arginine for a glycine at codon 15 (p.A15G) that was excluded in 300 healthy normal weight controls. The mutation segregated in the family and was associated with overweight, type 2 diabetes, hypertension and coronary heart disease in the carriers. Functional studies demonstrated that POMC protein was not detectable in β-TC3 cells transfected with A15G-POMC vector as well as in their culture media, despite POMC mRNA levels were comparable for amount and stability to those of wild-type-transfected cells. In silico RNA folding prediction indicated that the mutation gives rise to a different RNA secondary structure, suggesting that it might affect translation and protein synthesis. To the best of our knowledge, this is the first report addressing the functional consequences of a mutation in the signal peptide of POMC. These findings further support the hypothesis that POMC-derived peptides might have a role in the control of peripheral glucose metabolism and suggest that disruption of central POMC secretion might represent an additional link between type 2 diabetes and obesity.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Mountjoy KG : Functions for pro-opiomelanocortin-derived peptides in obesity and diabetes. Biochem J 2010; 428: 305–324.
Parton LE, Ye CP, Coppari R et al. Glucose sensing by POMC neurons regulates glucose homeostasis and is impaired in obesity. Nature 2007; 449: 228–232.
Fick LJ, Belsham DD : Nutrient sensing and insulin signaling in neuropeptide-expressing immortalized, hypothalamic neurons: A cellular model of insulin resistance. Cell Cycle 2010; 9: 3186–3193.
Coll AP, Challis BG, Lopez M, Piper S, Yeo GS, O'Rahilly S : Proopiomelanocortin-deficient mice are hypersensitive to the adverse metabolic effects of glucocorticoids. Diabetes 2005; 54: 2269–2276.
Coll AP : Effects of pro-opiomelanocortin (POMC) on food intake and body weight: mechanisms and therapeutic potential? Clin Sci (Lond) 2007; 113: 171–182.
Coll AP, Loraine Tung YC : Pro-opiomelanocortin (POMC)-derived peptides and the regulation of energy homeostasis. Mol Cell Endocrinol 2009; 300: 147–151.
Krude H, Biebermann H, Luck W, Horn R, Brabant G, Gruters A : Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 1998; 19: 155–157.
Krude H, Biebermann H, Schnabel D et al. Obesity due to proopiomelanocortin deficiency: three new cases and treatment trials with thyroid hormone and ACTH4-10. J Clin Endocrinol Metab 2003; 88: 4633–4640.
Farooqi IS, Drop S, Clements A et al. Heterozygosity for a POMC-null mutation and increased obesity risk in humans. Diabetes 2006; 55: 2549–2553.
Lee YS, Challis BG, Thompson DA et al. A POMC variant implicates beta-melanocyte-stimulating hormone in the control of human energy balance. Cell Metab 2006; 3: 135–140.
Creemers JW, Lee YS, Oliver RL et al. Mutations in the amino-terminal region of proopiomelanocortin (POMC) in patients with early-onset obesity impair POMC sorting to the regulated secretory pathway. J Clin Endocrinol Metab 2008; 93: 4494–4499.
Miraglia del Giudice E, Cirillo G, Santoro N et al. Molecular screening of the proopiomelanocortin (POMC) gene in Italian obese children: report of three new mutations. Int J Obes Relat Metab Disord 2001; 25: 61–67.
Santoro N, del Giudice EM, Cirillo G et al. An insertional polymorphism of the proopiomelanocortin gene is associated with fasting insulin levels in childhood obesity. J Clin Endocrinol Metab 2004; 89: 4846–4849.
Santoro N, Perrone L, Cirillo G et al. Weight loss in obese children carrying the proopiomelanocortin R236G variant. J Endocrinol Invest 2006; 29: 226–230.
Tortorella A, Monteleone P, del Giudice EM et al. Melanocortin-4 receptor molecular scanning and pro-opiomelanocortin R236G variant screening in binge eating disorder. Psychiatr Genet 2005; 15: 161.
Rost B, Liu J : The PredictProtein server. Nucleic Acids Res 2003; 31: 3300–3304.
Zuker M : Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res 2003; 31: 3406–3415.
Zuker M, Stiegler P : Optimal computer folding of large RNA sequences using thermodynamics and auxiliary information. Nucleic Acids Res 1981; 9: 133–148.
O'Rahilly S : Human genetics illuminates the paths to metabolic disease. Nature 2009; 462: 307–314.
Michailidou Z, Coll AP, Kenyon CJ et al. Peripheral mechanisms contributing to the glucocorticoid hypersensitivity in proopiomelanocortin null mice treated with corticosterone. J Endocrinol 2007; 194: 161–170.
Challis BG, Pritchard LE, Creemers JW et al. A missense mutation disrupting a dibasic prohormone processing site in pro-opiomelanocortin (POMC) increases susceptibility to early-onset obesity through a novel molecular mechanism. Hum Mol Genet 2002; 11: 1997–2004.
Biebermann H, Castaneda TR, van Landeghem F et al. A role for beta-melanocyte-stimulating hormone in human body-weight regulation. Cell Metab 2006; 3: 141–146.
Mohren S, Weiskirchen R : Non-synonymous gene polymorphisms in the secretory signal peptide of human TGF-beta1 affect cellular synthesis but not secretion of TGF-beta1. Biochem Biophys Res Commun 2009; 379: 1015–1020.
Butler AA, Kesterson RA, Khong K et al. A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology 2000; 141: 3518–3521.
Chen AS, Marsh DJ, Trumbauer ME et al. Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat Genet 2000; 26: 97–102.
Ni XP, Humphreys MH : Abnormal glucose metabolism in hypertensive mice with genetically interrupted gamma-melanocyte stimulating hormone signaling fed a high-sodium diet. Am J Hypertens 2008; 21: 1284–1287.
Fan W, Dinulescu DM, Butler AA, Zhou J, Marks DL, Cone RD : The central melanocortin system can directly regulate serum insulin levels. Endocrinology 2000; 141: 3072–3079.
Huszar D, Lynch CA, Fairchild-Huntress V et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997; 88: 131–141.
Banno R, Arima H, Hayashi M et al. Central administration of melanocortin agonist increased insulin sensitivity in diet-induced obese rats. FEBS Lett 2007; 581: 1131–1136.
Obici S, Feng Z, Tan J, Liu L, Karkanias G, Rossetti L : Central melanocortin receptors regulate insulin action. J Clin Invest 2001; 108: 1079–1085.
Barzilai N, She L, Liu L et al. Decreased visceral adiposity accounts for leptin effect on hepatic but not peripheral insulin action. Am J Physiol 1999; 277: E291–E298.
Liu L, Karkanias GB, Morales JC et al. Intracerebroventricular leptin regulates hepatic but not peripheral glucose fluxes. J Biol Chem 1998; 273: 31160–31167.
Stanley S, Pinto S, Segal J et al. Identification of neuronal subpopulations that project from hypothalamus to both liver and adipose tissue polysynaptically. Proc Natl Acad Sci USA 2010; 107: 7024–7029.
Chai B, Li JY, Zhang W, Wang H, Mulholland MW : Melanocortin-4 receptor activation inhibits c-Jun N-terminal kinase activity and promotes insulin signaling. Peptides 2009; 30: 1098–1104.
Minder EI : Afamelanotide an agonistic analog of alpha-melanocyte-stimulating hormone, in dermal phototoxicity of erythropoietic protoporphyria. Expert Opin Investig Drugs 2010; 19: 1591–1602.
Acknowledgements
We would like to thank the patient and her relatives for the kind collaboration.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on European Journal of Human Genetics website
Supplementary information
Rights and permissions
About this article
Cite this article
Mencarelli, M., Zulian, A., Cancello, R. et al. A novel missense mutation in the signal peptide of the human POMC gene: a possible additional link between early-onset type 2 diabetes and obesity. Eur J Hum Genet 20, 1290–1294 (2012). https://doi.org/10.1038/ejhg.2012.103
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/ejhg.2012.103
